GENTAMICIVEN
GENTAMICIVEN
Not authorised
- Gentamicin sulfate
Product identification
Medicine name:
GENTAMICIVEN
Active substance:
- Gentamicin sulfate
Target species:
-
Dog
-
Cat
-
Cattle (calf)
-
Horse (non food-producing)
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Gentamicin sulfate40.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle (calf)
-
Meat and offal192day
-
Milkno withdrawal periodLeche: No administrar a hembras en lactación cuya
-
-
-
Intravenous use
-
Cattle (calf)
-
Meat and offal192day
-
Milkno withdrawal periodLeche: No administrar a hembras en lactación cuya
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01GB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios E Industrias Iven S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios E Industrias Iven S.A.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 641 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022